This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Formulation Development Outsourcing Market

Market Insights on Formulation Development Outsourcing covering sales outlook, demand forecast & up-to-date key trends

Formulation Development Outsourcing Market by Service, Formulation, Therapeutic Area & Region - Forecast 2022 – 2032

Formulation Development Outsourcing Market Outlook (2022-2032)

[306 Pages Report] The formulation development outsourcing market is anticipated to have an impressive CAGR of 7.2% during the period of 2022-2032. According to FMI, the formulation development outsourcing market is expected to grow from US$ 31 billion in 2021 to US$ 66.6 billion by 2032.

“The need for generic drugs and biosimilars is anticipated to increase in developed nations, and the pharmaceutical industry's critical need for innovation is driving up demand for formulation development outsourcing.”

The rising need for novel medications as a result of the significant burden of infectious and chronic diseases is one of the main factors driving the demand for formulation development outsourcing. In addition, there is a strong emphasis on creating poorly water-soluble chemicals to increase bioavailability and patent expirations.

Additionally, the demand for methods to reduce the risk involved in development is expanding, which is fueling the formulation development outsourcing market expansion.

The formulation development outsourcing market is a crucial component of medicine or product development, since it affects a pharmaceutical product's success, patentability, and lifetime.

Attributes

Details

Formulation Development Outsourcing Market CAGR (2022-2032)

7.2%

Formulation Development Outsourcing Market Size (2021)

US$ 31 billion

Formulation Development Outsourcing Market Size (2032)

US$ 66.6 billion

The pharmaceutical industry's pursuit of novel and efficient medicines continues to fuel longer-term growth, and clinical research for both new and existing COVID-19 medications continues to flourish. Contrast Research Organizations, or CROs, and biotechnology start-up businesses began creating formulations to fight disease.

The majority of pharmaceutical businesses employ it to cut down on the amount of time spent formulation development outsourcing services due to trial-related investment. The growing emphasis of biopharmaceutical companies that have developed academic relationships is attributed to the formulation development outsourcing market growth.

Customize this Report

Let us know your requirement to get
100% FREE customization

What Factors are Contributing to the Growth of the Formulation Development Outsourcing Market?

The demand for formulation development outsourcing services is anticipated to increase as a result of the rising R&D expenditures. Small and medium-sized pharmaceutical enterprises that lack the capacity for formulation development frequently use formulation development services.

Furthermore, to remain competitive and adaptable, pharmaceutical companies are increasingly concentrating on their R&D efforts. The patent expiration of important pharmaceuticals was accelerated due to the growing significance of novel drugs and their use.

Most pharmaceutical companies, who are the main market drivers of the formulation development outsourcing market, are increasing the outsourcing of their formulation services as a result of this. Cancer research in the UK supports early drug development and provides funding to numerous pharmaceutical firms.

What are the Stumbling Blocks in the Formulation Development Outsourcing Market?

Formulation development outsourcing market growth is anticipated to be constrained by rising instrument prices needed for testing, diagnosis, and treatment. Structure changes in the pharmaceutical industry also affect the growth of the formulation development outsourcing market share.

The rise in price and demand for various pharmaceuticals and raw materials can have a significant negative impact on the market value of formulation development outsourcing.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Comparative View of Adjacent Formulation Development Outsourcing Market

Formulation Development Outsourcing Market:

Attributes

Formulation Development Outsourcing Market

CAGR (2022-2032)

7.2%

Market Value (2032)

US$ 66.6 billion

Growth Factor

Demand is high in response to the increased R&D activities in the field.

Opportunity

The market offers more prospects as the number of pharmaceutical and biopharmaceutical companies grows.

Key Trends

To boost bioavailability and patent expirations, a lot of focus is being placed on developing compounds that aren't very water soluble.

Oral Solid Dosage Pharmaceutical Formulation Market:

Attributes

Oral Solid Dosage Pharmaceutical Formulation Market

CAGR (2022-2032)

6.5%

Market Value (2032)

US$ 1118.92 Billion

Growth Factor

Properties such as cost-effective and easy to manufacture are accelerating the demand.

Opportunity

Sharp rise in new affluent consumers in developed nations provides lucrative opportunities in the market.

Key Trends

Recent advances in drug delivery are enabling oral solid dosage manufacturers to achieve significant bioavailability by adopting novel drug delivery technology platforms.

Aseptic Formulation Market:

Attributes

Aseptic Formulation Market

CAGR (2022-2032)

10.6%

Market Value (2032)

US$ 211.57 billion

Growth Factor

Growing awareness about using highly integrated sterile devices is driving up demand.

Opportunity

The market is being promoted by a development of new therapeutic drugs.

Key Trends

Increase in pharmaceutical supplies and improved sanitary packaging methods provide market better chances.

The formulation development outsourcing market created marketing by looking at the medical drug patent protection expiration in order to spur market expansion. Formulation development outsourcing market size has expanded due to the increasing number of biopharmaceutical and pharmaceutical firms that outsource their services.

It is projected that the substantial number of small and medium-sized pharmaceutical enterprises which accelerate the formulation development outsourcing market expansion. New technologies for formulation development are now being developed by pharmaceutical researchers.

For instance, a paper on the use of 3D printing for the formulation creation of individualized medications was published in June 2021 by Taylor France online. The adoption of new technologies in research is anticipated to increase demand for formulation development outsourcing.

Due to issues with formulation development, a significant number of medications do not make it to late-stage clinical trials. Additionally, the demand for formulation development outsourcing is being fueled by stringent rules governing the creation of pharmaceuticals.

The formulation development outsourcing market dynamics variables include the drivers, opportunities, restraints, and challenges, as well as the impact of these factors on the market. The drivers and limits are intrinsic to the formulation development outsourcing market, while the possibilities and difficulties are extrinsic.

The formulation development outsourcing market outlook projects revenue growth throughout the forecast period. The value of the formulation development outsourcing market is expected to rise as a result of the growing support for patents in drugs. The value chain in the market is promoted and enhanced by a number of variables, including supply chain development and the key player.

Segmentation Outlook

What is the Service Segment Outlook of the Formulation Development Outsourcing Market?

With a revenue share of 76.6% in 2021, the formulation development segment dominated the market for formulation development outsourcing. Every stage of clinical trials requires the development of a formulation, and the quantity of clinical research has greatly expanded over time.

The market for formulation development outsourcing is projected to benefit if a sizable number of businesses outsource formulation development services. The rising frequency of chronic diseases, including cancer, diabetes, HIV, and other illnesses, is also encouraging the need for formulation development by increasing the demand for producing novel medicines.

Which Segment is Leading in the Formulation Development Outsourcing Market by Formulation?

“In 2021, the oral segment dominated the market for formulation development outsourcing, accounting for the highest revenue share at 63.6%.

Tablets, capsules, syrups, and powders are a few examples of oral formulations. As they are primarily used to treat some common disorders like migraines, infectious diseases, fever, and diabetes, among others, oral formulations have grown significantly in formulation development outsourcing market share.

One of the main factors contributing to oral formulations' great acceptability is its self-administrability and lack of need for a skilled physician to provide the medication. Additionally, compared to others, these formulations have more design flexibility, which increases their demand for formulation development outsourcing.

In the formulation development outsourcing market, the injectable formulation sector is anticipated to grow at the quickest rate (7.8% CAGR). The primary driver for its quickest growth is the high bioavailability of injectable formulations, which results in an instantaneous commencement of effect.

Additionally, if the medications are poorly absorbed, injectable forms are favored. This type of formulation is also frequently chosen in medical situations, which is propelling the market even more.

Which Segment has the highest potential in the Formulation Development Outsourcing Market by Therapeutic Area?

The cancer therapeutic area dominated the formulation development outsourcing market share and accumulated the greatest revenue share of 24.5% in 2021. The quickest CAGR during the projection period is also anticipated for this market category.

The need for innovative cancer medicines has been greatly influenced by the fact that cancer is one of the leading causes of mortality in the globe. Additionally, a sizable number of organizations finance cancer research.

For instance, the World Cancer Research Fund International offers investigator-initiated trials of more than GBP 300,000 over a three-year period. Additionally, the NCI generously funds a lot of cancer research.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

What is the Regional Formulation Development Outsourcing Market Outlook?

Asia Pacific Outlook

With a revenue share of 39.1% in 2021, Asia Pacific dominated the market for formulation development outsourcing. The quickest CAGR of 8.1% over the forecast period is also anticipated for the area.

One of the main factors contributing to the greatest formulation development outsourcing market share is the existence of a sizable number of CROs providing affordable formulation developing services. Public groups are also making efforts to shorten the time it takes for drugs to be approved in the area.

Europe Outlook

Furthermore, it is predicted that Europe would have the second-largest formulation development outsourcing market share. The market in this region is being driven by the government's supportive activities, sedentary lifestyles, and rising chronic disorders.

North America Outlook

In North America, the market for formulation development outsourcing maintained a sizable proportion of 26.8% in 2021. For instance, a large number of clinical trials are carried out in the United States.

In addition, public U.S. organizations provide financial assistance for the research. As a result, the market in this area is being driven by the rising incidence of chronic diseases and the development of new medications.

Key players are active in the creation of novel therapeutics, as the majority of the medications are approaching the point of patent expiration. Pharmaceutical companies are outsourcing formulation development services to CROs in this situation to save time and money on a number of clinical trials and assessment studies, which could propel market expansion in the area.

How Competition Affects the Formulation Development Outsourcing Market?

Presently, there are several market players that are becoming fiercely competitive in the formulation development outsourcing market share. Few of the competitors are likely to capture the maximum portion of the formulation development outsourcing market.

Due to the presence of numerous major competitors, the formulation development outsourcing market is fragmented.

Recent Developments

  • 2020 saw the announcement by Catalent Inc. of the acquisition of MaStherCell Global Inc. The biotech sector is strengthening its position as a result of this increase, and new methods for gene therapies are made available.
  • In 2019, Intertek enlarged its Melbourne-based laboratory for pharmaceutical services.
  • In 2021, Cataleny Inc. announced that it has acquired the packaging and manufacturing divisions of Acorda Therapeutics Inc.
  • In 2021, Quotient BioSciences also disclosed plans to acquire Arcinova, a UK-based business. With this acquisition, Quotient Bioscience is able to offer more services, such as medicinal goods, clinical testing, and drug substance development.

Key Players

  • SGS S.A.
  • Intertek Group plc
  • Recipharm
  • Lonza
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific SE
  • Element
  • Labcorp
  • Thermo Fisher Scientific, Inc. (Patheon)
  • Catalent Inc.

Key Segments

By Service:

  • Preformulation
  • Formulation Development

By Formulation:

  • Oral
  • Injectable

By Therapeutic Area:

  • Oncology
  • Infectious Diseases
  • Neurology
  • Hematology
  • Respiratory
  • Cardiovascular
  • Dermatology
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Frequently Asked Questions

The green technology and sustainability market is projected to have a CAGR of 7.2% through 2032.

The formulation development outsourcing market size is anticipated to be US$ 66.6 billion through 2032.

The formulation development outsourcing market size is US$ 31 billion in 2021.

Formulation development segment holds the largest revenue share of 76.6% in the market.

Oral segment led the market with a revenue share of 63.6% during the forecast period.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity 

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Formulation Development Outsourcing Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Formulation Development Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Service

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Service, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Service, 2022-2032

        5.3.1. Preformulation

        5.3.2. Formulation Development

    5.4. Y-o-Y Growth Trend Analysis By Service, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Service, 2022-2032

6. Global Formulation Development Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Formulation

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Formulation, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Formulation, 2022-2032

        6.3.1. Oral

        6.3.2. Injectable

        6.3.3. Topical

        6.3.4. Others

    6.4. Y-o-Y Growth Trend Analysis By Formulation, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Formulation, 2022-2032

7. Global Formulation Development Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Therapeutic Area

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Mn) Analysis By Therapeutic Area, 2017-2021

    7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Therapeutic Area, 2022-2032

        7.3.1. Oncology

        7.3.2. Infectious Diseases

        7.3.3. Neurology

        7.3.4. Hematology

        7.3.5. Respiratory

        7.3.6. Cardiovascular

        7.3.7. Dermatology

        7.3.8. Others

    7.4. Y-o-Y Growth Trend Analysis By Therapeutic Area, 2017-2021

    7.5. Absolute $ Opportunity Analysis By Therapeutic Area, 2022-2032

8. Global Formulation Development Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

    8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. Asia Pacific

        8.3.5. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Formulation Development Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. U.K.

            9.2.1.2. Canada

        9.2.2. By Service

        9.2.3. By Formulation

        9.2.4. By Therapeutic Area

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Service

        9.3.3. By Formulation

        9.3.4. By Therapeutic Area

    9.4. Key Takeaways

10. Latin America Formulation Development Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Service

        10.2.3. By Formulation

        10.2.4. By Therapeutic Area

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Service

        10.3.3. By Formulation

        10.3.4. By Therapeutic Area

    10.4. Key Takeaways

11. Europe Formulation Development Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. U.K.

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Europe

        11.2.2. By Service

        11.2.3. By Formulation

        11.2.4. By Therapeutic Area

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Service

        11.3.3. By Formulation

        11.3.4. By Therapeutic Area

    11.4. Key Takeaways

12. Asia Pacific Formulation Development Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

            12.2.1.4. Malaysia

            12.2.1.5. Singapore

            12.2.1.6. Australia

            12.2.1.7. Rest of Asia Pacific

        12.2.2. By Service

        12.2.3. By Formulation

        12.2.4. By Therapeutic Area

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Service

        12.3.3. By Formulation

        12.3.4. By Therapeutic Area

    12.4. Key Takeaways

13. MEA Formulation Development Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. GCC Countries

            13.2.1.2. South Africa

            13.2.1.3. Israel

            13.2.1.4. Rest of MEA

        13.2.2. By Service

        13.2.3. By Formulation

        13.2.4. By Therapeutic Area

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Service

        13.3.3. By Formulation

        13.3.4. By Therapeutic Area

    13.4. Key Takeaways

14. Key Countries Formulation Development Outsourcing Market Analysis

    14.1. U.K.

        14.1.1. Pricing Analysis

        14.1.2. Market Share Analysis, 2021

            14.1.2.1. By Service

            14.1.2.2. By Formulation

            14.1.2.3. By Therapeutic Area

    14.2. Canada

        14.2.1. Pricing Analysis

        14.2.2. Market Share Analysis, 2021

            14.2.2.1. By Service

            14.2.2.2. By Formulation

            14.2.2.3. By Therapeutic Area

    14.3. Brazil

        14.3.1. Pricing Analysis

        14.3.2. Market Share Analysis, 2021

            14.3.2.1. By Service

            14.3.2.2. By Formulation

            14.3.2.3. By Therapeutic Area

    14.4. Mexico

        14.4.1. Pricing Analysis

        14.4.2. Market Share Analysis, 2021

            14.4.2.1. By Service

            14.4.2.2. By Formulation

            14.4.2.3. By Therapeutic Area

    14.5. Rest of Latin America

        14.5.1. Pricing Analysis

        14.5.2. Market Share Analysis, 2021

            14.5.2.1. By Service

            14.5.2.2. By Formulation

            14.5.2.3. By Therapeutic Area

    14.6. Germany

        14.6.1. Pricing Analysis

        14.6.2. Market Share Analysis, 2021

            14.6.2.1. By Service

            14.6.2.2. By Formulation

            14.6.2.3. By Therapeutic Area

    14.7. U.K.

        14.7.1. Pricing Analysis

        14.7.2. Market Share Analysis, 2021

            14.7.2.1. By Service

            14.7.2.2. By Formulation

            14.7.2.3. By Therapeutic Area

    14.8. France

        14.8.1. Pricing Analysis

        14.8.2. Market Share Analysis, 2021

            14.8.2.1. By Service

            14.8.2.2. By Formulation

            14.8.2.3. By Therapeutic Area

    14.9. Spain

        14.9.1. Pricing Analysis

        14.9.2. Market Share Analysis, 2021

            14.9.2.1. By Service

            14.9.2.2. By Formulation

            14.9.2.3. By Therapeutic Area

    14.10. Italy

        14.10.1. Pricing Analysis

        14.10.2. Market Share Analysis, 2021

            14.10.2.1. By Service

            14.10.2.2. By Formulation

            14.10.2.3. By Therapeutic Area

    14.11. Rest of Europe

        14.11.1. Pricing Analysis

        14.11.2. Market Share Analysis, 2021

            14.11.2.1. By Service

            14.11.2.2. By Formulation

            14.11.2.3. By Therapeutic Area

    14.12. China

        14.12.1. Pricing Analysis

        14.12.2. Market Share Analysis, 2021

            14.12.2.1. By Service

            14.12.2.2. By Formulation

            14.12.2.3. By Therapeutic Area

    14.13. Japan

        14.13.1. Pricing Analysis

        14.13.2. Market Share Analysis, 2021

            14.13.2.1. By Service

            14.13.2.2. By Formulation

            14.13.2.3. By Therapeutic Area

    14.14. South Korea

        14.14.1. Pricing Analysis

        14.14.2. Market Share Analysis, 2021

            14.14.2.1. By Service

            14.14.2.2. By Formulation

            14.14.2.3. By Therapeutic Area

    14.15. Malaysia

        14.15.1. Pricing Analysis

        14.15.2. Market Share Analysis, 2021

            14.15.2.1. By Service

            14.15.2.2. By Formulation

            14.15.2.3. By Therapeutic Area

    14.16. Singapore

        14.16.1. Pricing Analysis

        14.16.2. Market Share Analysis, 2021

            14.16.2.1. By Service

            14.16.2.2. By Formulation

            14.16.2.3. By Therapeutic Area

    14.17. Australia

        14.17.1. Pricing Analysis

        14.17.2. Market Share Analysis, 2021

            14.17.2.1. By Service

            14.17.2.2. By Formulation

            14.17.2.3. By Therapeutic Area

    14.18. Rest of Asia Pacific

        14.18.1. Pricing Analysis

        14.18.2. Market Share Analysis, 2021

            14.18.2.1. By Service

            14.18.2.2. By Formulation

            14.18.2.3. By Therapeutic Area

    14.19. GCC Countries

        14.19.1. Pricing Analysis

        14.19.2. Market Share Analysis, 2021

            14.19.2.1. By Service

            14.19.2.2. By Formulation

            14.19.2.3. By Therapeutic Area

    14.20. South Africa

        14.20.1. Pricing Analysis

        14.20.2. Market Share Analysis, 2021

            14.20.2.1. By Service

            14.20.2.2. By Formulation

            14.20.2.3. By Therapeutic Area

    14.21. Israel

        14.21.1. Pricing Analysis

        14.21.2. Market Share Analysis, 2021

            14.21.2.1. By Service

            14.21.2.2. By Formulation

            14.21.2.3. By Therapeutic Area

    14.22. Rest of MEA

        14.22.1. Pricing Analysis

        14.22.2. Market Share Analysis, 2021

            14.22.2.1. By Service

            14.22.2.2. By Formulation

            14.22.2.3. By Therapeutic Area

15. Market Structure Analysis

    15.1. Competition Dashboard

    15.2. Competition Benchmarking

    15.3. Market Share Analysis of Top Players

        15.3.1. By Regional

        15.3.2. By Service

        15.3.3. By Formulation

        15.3.4. By Therapeutic Area

16. Competition Analysis

    16.1. Competition Deep Dive

        16.1.1. SGS S.A.

            16.1.1.1. Overview

            16.1.1.2. Product Portfolio

            16.1.1.3. Profitability by Market Segments

            16.1.1.4. Sales Footprint

            16.1.1.5. Strategy Overview

                16.1.1.5.1. Marketing Strategy

        16.1.2. Intertek Group plc

            16.1.2.1. Overview

            16.1.2.2. Product Portfolio

            16.1.2.3. Profitability by Market Segments

            16.1.2.4. Sales Footprint

            16.1.2.5. Strategy Overview

                16.1.2.5.1. Marketing Strategy

        16.1.3. Recipharm

            16.1.3.1. Overview

            16.1.3.2. Product Portfolio

            16.1.3.3. Profitability by Market Segments

            16.1.3.4. Sales Footprint

            16.1.3.5. Strategy Overview

                16.1.3.5.1. Marketing Strategy

        16.1.4. Lonza

            16.1.4.1. Overview

            16.1.4.2. Product Portfolio

            16.1.4.3. Profitability by Market Segments

            16.1.4.4. Sales Footprint

            16.1.4.5. Strategy Overview

                16.1.4.5.1. Marketing Strategy

        16.1.5. Charles River Laboratories International, Inc.

            16.1.5.1. Overview

            16.1.5.2. Product Portfolio

            16.1.5.3. Profitability by Market Segments

            16.1.5.4. Sales Footprint

            16.1.5.5. Strategy Overview

                16.1.5.5.1. Marketing Strategy

        16.1.6. Eurofins Scientific SE

            16.1.6.1. Overview

            16.1.6.2. Product Portfolio

            16.1.6.3. Profitability by Market Segments

            16.1.6.4. Sales Footprint

            16.1.6.5. Strategy Overview

                16.1.6.5.1. Marketing Strategy

        16.1.7. Element

            16.1.7.1. Overview

            16.1.7.2. Product Portfolio

            16.1.7.3. Profitability by Market Segments

            16.1.7.4. Sales Footprint

            16.1.7.5. Strategy Overview

                16.1.7.5.1. Marketing Strategy

        16.1.8. Labcorp

            16.1.8.1. Overview

            16.1.8.2. Product Portfolio

            16.1.8.3. Profitability by Market Segments

            16.1.8.4. Sales Footprint

            16.1.8.5. Strategy Overview

                16.1.8.5.1. Marketing Strategy

        16.1.9. Thermo Fisher Scientific, Inc.

            16.1.9.1. Overview

            16.1.9.2. Product Portfolio

            16.1.9.3. Profitability by Market Segments

            16.1.9.4. Sales Footprint

            16.1.9.5. Strategy Overview

                16.1.9.5.1. Marketing Strategy

        16.1.10. Catalent Inc.

            16.1.10.1. Overview

            16.1.10.2. Product Portfolio

            16.1.10.3. Profitability by Market Segments

            16.1.10.4. Sales Footprint

            16.1.10.5. Strategy Overview

                16.1.10.5.1. Marketing Strategy

17. Assumptions & Acronyms Used

18. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Formulation Development Outsourcing Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Formulation Development Outsourcing Market Value (US$ Mn) Forecast by Service, 2017-2032

Table 3: Global Formulation Development Outsourcing Market Value (US$ Mn) Forecast by Formulation, 2017-2032

Table 4: Global Formulation Development Outsourcing Market Value (US$ Mn) Forecast by Therapeutic Area, 2017-2032

Table 5: North America Formulation Development Outsourcing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 6: North America Formulation Development Outsourcing Market Value (US$ Mn) Forecast by Service, 2017-2032

Table 7: North America Formulation Development Outsourcing Market Value (US$ Mn) Forecast by Formulation, 2017-2032

Table 8: North America Formulation Development Outsourcing Market Value (US$ Mn) Forecast by Therapeutic Area, 2017-2032

Table 9: Latin America Formulation Development Outsourcing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 10: Latin America Formulation Development Outsourcing Market Value (US$ Mn) Forecast by Service, 2017-2032

Table 11: Latin America Formulation Development Outsourcing Market Value (US$ Mn) Forecast by Formulation, 2017-2032

Table 12: Latin America Formulation Development Outsourcing Market Value (US$ Mn) Forecast by Therapeutic Area, 2017-2032

Table 13: Europe Formulation Development Outsourcing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 14: Europe Formulation Development Outsourcing Market Value (US$ Mn) Forecast by Service, 2017-2032

Table 15: Europe Formulation Development Outsourcing Market Value (US$ Mn) Forecast by Formulation, 2017-2032

Table 16: Europe Formulation Development Outsourcing Market Value (US$ Mn) Forecast by Therapeutic Area, 2017-2032

Table 17: Asia Pacific Formulation Development Outsourcing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 18: Asia Pacific Formulation Development Outsourcing Market Value (US$ Mn) Forecast by Service, 2017-2032

Table 19: Asia Pacific Formulation Development Outsourcing Market Value (US$ Mn) Forecast by Formulation, 2017-2032

Table 20: Asia Pacific Formulation Development Outsourcing Market Value (US$ Mn) Forecast by Therapeutic Area, 2017-2032

Table 21: MEA Formulation Development Outsourcing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 22: MEA Formulation Development Outsourcing Market Value (US$ Mn) Forecast by Service, 2017-2032

Table 23: MEA Formulation Development Outsourcing Market Value (US$ Mn) Forecast by Formulation, 2017-2032

Table 24: MEA Formulation Development Outsourcing Market Value (US$ Mn) Forecast by Therapeutic Area, 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Formulation Development Outsourcing Market Value (US$ Mn) by Service, 2022-2032

Figure 2: Global Formulation Development Outsourcing Market Value (US$ Mn) by Formulation, 2022-2032

Figure 3: Global Formulation Development Outsourcing Market Value (US$ Mn) by Therapeutic Area, 2022-2032

Figure 4: Global Formulation Development Outsourcing Market Value (US$ Mn) by Region, 2022-2032

Figure 5: Global Formulation Development Outsourcing Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 6: Global Formulation Development Outsourcing Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 7: Global Formulation Development Outsourcing Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 8: Global Formulation Development Outsourcing Market Value (US$ Mn) Analysis by Service, 2017-2032

Figure 9: Global Formulation Development Outsourcing Market Value Share (%) and BPS Analysis by Service, 2022-2032

Figure 10: Global Formulation Development Outsourcing Market Y-o-Y Growth (%) Projections by Service, 2022-2032

Figure 11: Global Formulation Development Outsourcing Market Value (US$ Mn) Analysis by Formulation, 2017-2032

Figure 12: Global Formulation Development Outsourcing Market Value Share (%) and BPS Analysis by Formulation, 2022-2032

Figure 13: Global Formulation Development Outsourcing Market Y-o-Y Growth (%) Projections by Formulation, 2022-2032

Figure 14: Global Formulation Development Outsourcing Market Value (US$ Mn) Analysis by Therapeutic Area, 2017-2032

Figure 15: Global Formulation Development Outsourcing Market Value Share (%) and BPS Analysis by Therapeutic Area, 2022-2032

Figure 16: Global Formulation Development Outsourcing Market Y-o-Y Growth (%) Projections by Therapeutic Area, 2022-2032

Figure 17: Global Formulation Development Outsourcing Market Attractiveness by Service, 2022-2032

Figure 18: Global Formulation Development Outsourcing Market Attractiveness by Formulation, 2022-2032

Figure 19: Global Formulation Development Outsourcing Market Attractiveness by Therapeutic Area, 2022-2032

Figure 20: Global Formulation Development Outsourcing Market Attractiveness by Region, 2022-2032

Figure 21: North America Formulation Development Outsourcing Market Value (US$ Mn) by Service, 2022-2032

Figure 22: North America Formulation Development Outsourcing Market Value (US$ Mn) by Formulation, 2022-2032

Figure 23: North America Formulation Development Outsourcing Market Value (US$ Mn) by Therapeutic Area, 2022-2032

Figure 24: North America Formulation Development Outsourcing Market Value (US$ Mn) by Country, 2022-2032

Figure 25: North America Formulation Development Outsourcing Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 26: North America Formulation Development Outsourcing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 27: North America Formulation Development Outsourcing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 28: North America Formulation Development Outsourcing Market Value (US$ Mn) Analysis by Service, 2017-2032

Figure 29: North America Formulation Development Outsourcing Market Value Share (%) and BPS Analysis by Service, 2022-2032

Figure 30: North America Formulation Development Outsourcing Market Y-o-Y Growth (%) Projections by Service, 2022-2032

Figure 31: North America Formulation Development Outsourcing Market Value (US$ Mn) Analysis by Formulation, 2017-2032

Figure 32: North America Formulation Development Outsourcing Market Value Share (%) and BPS Analysis by Formulation, 2022-2032

Figure 33: North America Formulation Development Outsourcing Market Y-o-Y Growth (%) Projections by Formulation, 2022-2032

Figure 34: North America Formulation Development Outsourcing Market Value (US$ Mn) Analysis by Therapeutic Area, 2017-2032

Figure 35: North America Formulation Development Outsourcing Market Value Share (%) and BPS Analysis by Therapeutic Area, 2022-2032

Figure 36: North America Formulation Development Outsourcing Market Y-o-Y Growth (%) Projections by Therapeutic Area, 2022-2032

Figure 37: North America Formulation Development Outsourcing Market Attractiveness by Service, 2022-2032

Figure 38: North America Formulation Development Outsourcing Market Attractiveness by Formulation, 2022-2032

Figure 39: North America Formulation Development Outsourcing Market Attractiveness by Therapeutic Area, 2022-2032

Figure 40: North America Formulation Development Outsourcing Market Attractiveness by Country, 2022-2032

Figure 41: Latin America Formulation Development Outsourcing Market Value (US$ Mn) by Service, 2022-2032

Figure 42: Latin America Formulation Development Outsourcing Market Value (US$ Mn) by Formulation, 2022-2032

Figure 43: Latin America Formulation Development Outsourcing Market Value (US$ Mn) by Therapeutic Area, 2022-2032

Figure 44: Latin America Formulation Development Outsourcing Market Value (US$ Mn) by Country, 2022-2032

Figure 45: Latin America Formulation Development Outsourcing Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 46: Latin America Formulation Development Outsourcing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 47: Latin America Formulation Development Outsourcing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 48: Latin America Formulation Development Outsourcing Market Value (US$ Mn) Analysis by Service, 2017-2032

Figure 49: Latin America Formulation Development Outsourcing Market Value Share (%) and BPS Analysis by Service, 2022-2032

Figure 50: Latin America Formulation Development Outsourcing Market Y-o-Y Growth (%) Projections by Service, 2022-2032

Figure 51: Latin America Formulation Development Outsourcing Market Value (US$ Mn) Analysis by Formulation, 2017-2032

Figure 52: Latin America Formulation Development Outsourcing Market Value Share (%) and BPS Analysis by Formulation, 2022-2032

Figure 53: Latin America Formulation Development Outsourcing Market Y-o-Y Growth (%) Projections by Formulation, 2022-2032

Figure 54: Latin America Formulation Development Outsourcing Market Value (US$ Mn) Analysis by Therapeutic Area, 2017-2032

Figure 55: Latin America Formulation Development Outsourcing Market Value Share (%) and BPS Analysis by Therapeutic Area, 2022-2032

Figure 56: Latin America Formulation Development Outsourcing Market Y-o-Y Growth (%) Projections by Therapeutic Area, 2022-2032

Figure 57: Latin America Formulation Development Outsourcing Market Attractiveness by Service, 2022-2032

Figure 58: Latin America Formulation Development Outsourcing Market Attractiveness by Formulation, 2022-2032

Figure 59: Latin America Formulation Development Outsourcing Market Attractiveness by Therapeutic Area, 2022-2032

Figure 60: Latin America Formulation Development Outsourcing Market Attractiveness by Country, 2022-2032

Figure 61: Europe Formulation Development Outsourcing Market Value (US$ Mn) by Service, 2022-2032

Figure 62: Europe Formulation Development Outsourcing Market Value (US$ Mn) by Formulation, 2022-2032

Figure 63: Europe Formulation Development Outsourcing Market Value (US$ Mn) by Therapeutic Area, 2022-2032

Figure 64: Europe Formulation Development Outsourcing Market Value (US$ Mn) by Country, 2022-2032

Figure 65: Europe Formulation Development Outsourcing Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 66: Europe Formulation Development Outsourcing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 67: Europe Formulation Development Outsourcing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 68: Europe Formulation Development Outsourcing Market Value (US$ Mn) Analysis by Service, 2017-2032

Figure 69: Europe Formulation Development Outsourcing Market Value Share (%) and BPS Analysis by Service, 2022-2032

Figure 70: Europe Formulation Development Outsourcing Market Y-o-Y Growth (%) Projections by Service, 2022-2032

Figure 71: Europe Formulation Development Outsourcing Market Value (US$ Mn) Analysis by Formulation, 2017-2032

Figure 72: Europe Formulation Development Outsourcing Market Value Share (%) and BPS Analysis by Formulation, 2022-2032

Figure 73: Europe Formulation Development Outsourcing Market Y-o-Y Growth (%) Projections by Formulation, 2022-2032

Figure 74: Europe Formulation Development Outsourcing Market Value (US$ Mn) Analysis by Therapeutic Area, 2017-2032

Figure 75: Europe Formulation Development Outsourcing Market Value Share (%) and BPS Analysis by Therapeutic Area, 2022-2032

Figure 76: Europe Formulation Development Outsourcing Market Y-o-Y Growth (%) Projections by Therapeutic Area, 2022-2032

Figure 77: Europe Formulation Development Outsourcing Market Attractiveness by Service, 2022-2032

Figure 78: Europe Formulation Development Outsourcing Market Attractiveness by Formulation, 2022-2032

Figure 79: Europe Formulation Development Outsourcing Market Attractiveness by Therapeutic Area, 2022-2032

Figure 80: Europe Formulation Development Outsourcing Market Attractiveness by Country, 2022-2032

Figure 81: Asia Pacific Formulation Development Outsourcing Market Value (US$ Mn) by Service, 2022-2032

Figure 82: Asia Pacific Formulation Development Outsourcing Market Value (US$ Mn) by Formulation, 2022-2032

Figure 83: Asia Pacific Formulation Development Outsourcing Market Value (US$ Mn) by Therapeutic Area, 2022-2032

Figure 84: Asia Pacific Formulation Development Outsourcing Market Value (US$ Mn) by Country, 2022-2032

Figure 85: Asia Pacific Formulation Development Outsourcing Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 86: Asia Pacific Formulation Development Outsourcing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 87: Asia Pacific Formulation Development Outsourcing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 88: Asia Pacific Formulation Development Outsourcing Market Value (US$ Mn) Analysis by Service, 2017-2032

Figure 89: Asia Pacific Formulation Development Outsourcing Market Value Share (%) and BPS Analysis by Service, 2022-2032

Figure 90: Asia Pacific Formulation Development Outsourcing Market Y-o-Y Growth (%) Projections by Service, 2022-2032

Figure 91: Asia Pacific Formulation Development Outsourcing Market Value (US$ Mn) Analysis by Formulation, 2017-2032

Figure 92: Asia Pacific Formulation Development Outsourcing Market Value Share (%) and BPS Analysis by Formulation, 2022-2032

Figure 93: Asia Pacific Formulation Development Outsourcing Market Y-o-Y Growth (%) Projections by Formulation, 2022-2032

Figure 94: Asia Pacific Formulation Development Outsourcing Market Value (US$ Mn) Analysis by Therapeutic Area, 2017-2032

Figure 95: Asia Pacific Formulation Development Outsourcing Market Value Share (%) and BPS Analysis by Therapeutic Area, 2022-2032

Figure 96: Asia Pacific Formulation Development Outsourcing Market Y-o-Y Growth (%) Projections by Therapeutic Area, 2022-2032

Figure 97: Asia Pacific Formulation Development Outsourcing Market Attractiveness by Service, 2022-2032

Figure 98: Asia Pacific Formulation Development Outsourcing Market Attractiveness by Formulation, 2022-2032

Figure 99: Asia Pacific Formulation Development Outsourcing Market Attractiveness by Therapeutic Area, 2022-2032

Figure 100: Asia Pacific Formulation Development Outsourcing Market Attractiveness by Country, 2022-2032

Figure 101: MEA Formulation Development Outsourcing Market Value (US$ Mn) by Service, 2022-2032

Figure 102: MEA Formulation Development Outsourcing Market Value (US$ Mn) by Formulation, 2022-2032

Figure 103: MEA Formulation Development Outsourcing Market Value (US$ Mn) by Therapeutic Area, 2022-2032

Figure 104: MEA Formulation Development Outsourcing Market Value (US$ Mn) by Country, 2022-2032

Figure 105: MEA Formulation Development Outsourcing Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 106: MEA Formulation Development Outsourcing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 107: MEA Formulation Development Outsourcing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 108: MEA Formulation Development Outsourcing Market Value (US$ Mn) Analysis by Service, 2017-2032

Figure 109: MEA Formulation Development Outsourcing Market Value Share (%) and BPS Analysis by Service, 2022-2032

Figure 110: MEA Formulation Development Outsourcing Market Y-o-Y Growth (%) Projections by Service, 2022-2032

Figure 111: MEA Formulation Development Outsourcing Market Value (US$ Mn) Analysis by Formulation, 2017-2032

Figure 112: MEA Formulation Development Outsourcing Market Value Share (%) and BPS Analysis by Formulation, 2022-2032

Figure 113: MEA Formulation Development Outsourcing Market Y-o-Y Growth (%) Projections by Formulation, 2022-2032

Figure 114: MEA Formulation Development Outsourcing Market Value (US$ Mn) Analysis by Therapeutic Area, 2017-2032

Figure 115: MEA Formulation Development Outsourcing Market Value Share (%) and BPS Analysis by Therapeutic Area, 2022-2032

Figure 116: MEA Formulation Development Outsourcing Market Y-o-Y Growth (%) Projections by Therapeutic Area, 2022-2032

Figure 117: MEA Formulation Development Outsourcing Market Attractiveness by Service, 2022-2032

Figure 118: MEA Formulation Development Outsourcing Market Attractiveness by Formulation, 2022-2032

Figure 119: MEA Formulation Development Outsourcing Market Attractiveness by Therapeutic Area, 2022-2032

Figure 120: MEA Formulation Development Outsourcing Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Healthcare Regulatory Affairs Outsourcing Market

Published : December 2021

Healthcare

Early Phase Clinical Trial Outsourcing Market

Published : January 2017

Google translate

Formulation Development Outsourcing Market